Apisofia

Apisofia is a biotechnology company dedicated to extending human healthspan by leveraging the unique biology of the honeybee. The company identifies and develops longevity-promoting compounds found in royal jelly and other bee-derived substances, focusing on the molecular mechanisms that allow queen bees to live significantly longer than worker bees despite sharing the same genome. Their research targets epigenetic and metabolic pathways to translate these findings into therapeutics for age-related decline and metabolic health. Apisofia's approach combines evolutionary biology with modern drug discovery to unlock new interventions for human longevity. The company's platform identifies unique proteins and small molecules with potential anti-aging properties for translation into human medicine.